Ortho Clinical Diagnostics announced its VITROS® Anti-SARS-CoV-2 IgG Quantitative Test is the first quantitative COVID-19 IgG antibody test to receive U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA).
Ortho Clinical Diagnostics, one of the world's largest pure-play in vitro diagnostics companies, announced its quantitative COVID-19 IgG antibody test achieved CE Mark.
Quansys Biosciences announced the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its laboratory-based IgG antibody test.